Please provide your email address to receive an email when new articles are posted on . Transurethral resection of bladder tumor plus systemic therapy induced clinical complete response among a large ...
Despite transurethral resection (TUR) and intravesical instillation of the most effective agents, a proportion of patients with transitional cell carcinoma of the bladder suffer a recurrence of their ...
The committee noted that the name change from TURis to PLASMA was not accompanied by any change to the technology. Therefore, they concluded that the previous evidence of equivalent clinical outcomes ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
Following a transurethral resection (TUR) prostatectomy for a benign enlargement, the patient complains of the lack of ejaculation and little emission, although he has a good erection. He does not ...
EORTC GUCG 2418 - STARBURST: Strategies for treatment adaptation following re-evaluation of the bladder after using primary neoadjuvant systemic therapies—An EORTC platform trial. This is an ASCO ...
A person may need surgery for bladder cancer to remove the tumor. A person may also need preoperative or postoperative treatments. Bladder cancer occurs when cells of the bladder start to grow out of ...
Richard T. Bryan, PhD, Wenyu Liu, PhD, Sarah J. Pirrie, MSc, Rashid Amir, FRCR, Jean Gallagher, Ana I. Hughes, MSc, Kieran P. Jefferson, FRCS, Allen Knight, MBA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback